Clinical Trial Update: Phase II Clinical Study of HRS-9563 in Patients With Mild to Moderate Hypertension [Phase 2]

View source ↗

Summary

Phase II clinical trial update for HRS-9563 in patients with mild to moderate hypertension is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• HRS-9563

Snippet

Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd. | Conditions: Mild to Moderate Hypertension | Phase 2 | Status: RECRUITING